These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34903694)

  • 1. Lymphocyte Subsets Are Associated with Disease Status in Neuromyelitis Optica Spectrum Disorders.
    Yang H; Liu W; Wu YF; Zhu DS; Shen XF; Guan YT
    Neuroimmunomodulation; 2022; 29(4):296-305. PubMed ID: 34903694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The frequencies of peripheral blood CD5
    Khani L; Jazayeri MH; Nedaeinia R; Bozorgmehr M; Nabavi SM; Ferns GA
    Allergy Asthma Clin Immunol; 2022 Jan; 18(1):5. PubMed ID: 35031055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral CD19
    Ellrichmann G; Bolz J; Peschke M; Duscha A; Hellwig K; Lee DH; Linker RA; Gold R; Haghikia A
    J Neurol; 2019 Jan; 266(1):57-67. PubMed ID: 30377816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
    Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
    Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating regulatory B cell subsets in patients with neuromyelitis optica spectrum disorders.
    Han J; Sun L; Wang Z; Fan X; Wang L; Song YY; Zhu J; Jin T
    Neurol Sci; 2017 Jul; 38(7):1205-1212. PubMed ID: 28389940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum IgG galactosylation is associated with increased inflammation during relapses of neuromyelitis optica spectrum disorders.
    Gao S; Jiao X; Guo R; Song X; Li B; Guo L
    Front Immunol; 2024; 15():1357475. PubMed ID: 38576616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the Clinical Characteristics in Patients with Neuromyelitis Optica Spectrum Disorders and Clinical Immune Indicators: A Retrospective Study.
    Cai L; Shi Z; Chen H; Du Q; Zhang Y; Zhao Z; Wang J; Lang Y; Kong L; Zhou H
    Brain Sci; 2022 Mar; 12(3):. PubMed ID: 35326328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of LAP
    Cai H; Liu Y; Dong X; Jiang F; Li H; Ouyang S; Yin W; He T; Zeng Q; Yang H
    Neurol Sci; 2023 May; 44(5):1739-1747. PubMed ID: 36683084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8
    Shi Z; Qiu Y; Zhao Z; Wen D; Chen H; Du Q; Zhang Y; Wang J; Yan C; Yang M; Zhou H
    Ann Clin Transl Neurol; 2021 Jan; 8(1):43-53. PubMed ID: 33231379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Alteration of Circulating Lymphocyte Subsets During Tacrolimus Therapy in Neuromyelitis Optica Spectrum Disorder and Its Correlation With Clinical Outcomes.
    Wang L; Huang W; ZhangBao J; Chang X; Tan H; Zhou L; Lu C; Wang M; Lu J; Zhao C; Quan C
    Front Neurol; 2021; 12():816721. PubMed ID: 35126303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral Blood Th1/Th17 Immune Cell Shift is Associated with Disease Activity and Severity of AQP4 Antibody Sero-Positive Neuromyelitis Optica Spectrum Disorder.
    Cao F; Wang Y; Wei R; Li C; Cheng Y; Zhou Y; Jin T; Zhang H; Lin L; Xu B
    Neuropsychiatr Dis Treat; 2023; 19():2413-2421. PubMed ID: 37965529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Balance in T Follicular Helper Cell Subsets Is Altered in Neuromyelitis Optica Spectrum Disorder Patients and Restored by Rituximab.
    Nicolas P; Ruiz A; Cobo-Calvo A; Fiard G; Giraudon P; Vukusic S; Marignier R
    Front Immunol; 2019; 10():2686. PubMed ID: 31803192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte subpopulations in patients with advanced breast cancer submitted to neoadjuvant chemotherapy.
    Murta EF; de Andrade JM; Falcão RP; Bighetti S
    Tumori; 2000; 86(5):403-7. PubMed ID: 11130570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
    Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
    Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
    Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
    J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.
    Nishiyama S; Wright AE; Lotan I; Mikami T; Paul F; Aoki M; Levy M
    J Neuroinflammation; 2022 Dec; 19(1):296. PubMed ID: 36503481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant Alteration of Circulating Lymphocyte Subsets in Small Cell Lung Cancer Patients Treated with Radiotherapy.
    Li H; Yu H; Lan S; Zhao D; Liu Y; Cheng Y
    Technol Cancer Res Treat; 2021; 20():15330338211039948. PubMed ID: 34851203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.